drugset / Trial / NCT02098187
Pharmacokinetics of MP-3180 and Use of Noninvasive Fluorescence Detection Device in Healthy Volunteers
RandomizedParallel-groupOpen-labelBasic science
Summary
The purpose of this early feasibility study was to investigate the pharmacokinetics of MP-3180 administered in rising doses and to evaluate the use of the Optical Renal Function Monitor (ORFM), an investigational noninvasive fluorescence detection device.
Timeline
- Start
- 2014-03
- Primary completion
- 2014-03
- Completion
- 2014-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | MP-3180 | Diagnostic / imaging agent | 0.186 mg/kg | Intravenous |
| Comparator | MP-3180 | Diagnostic / imaging agent | 0.744 mg/kg | Intravenous |
| Comparator | MP-3180 | Diagnostic / imaging agent | 1.488 mg/kg | Intravenous |